Cochrane · systematic review · CD008084

Glucocorticoid with cyclophosphamide for oral paraquat poisoning

Li, LR, Chaudhary, B, You, C, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

InjuriesAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
3
No studies
1
Included studies
NR
No studies 1 · 25%Ungraded 0 · 0%Very low 1 · 25%Low 2 · 50%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Glucocorticoid with cyclophosphamide plus usual care compared to usual care (with or without placebo) for oral paraquat poisoning

Population: people with moderate to severe oral paraquat poisoning
4 questions
OutcomeEffectEvidenceStatus / GRADE
Mortality at 30 days following the ingestion of paraquat
Glucocorticoid with cyclophosphamide plus usual care vs usual care (with or without placebo)
no estimate extractedNRNo studies
All‐cause mortality at final
Glucocorticoid with cyclophosphamide plus usual care vs usual care (with or without placebo)
RR 0.822 studies · 322 participantsLow
Downgraded: imprecision, inconsistency
All‐cause mortality at final
Glucocorticoid with cyclophosphamide plus usual care vs usual care (with or without placebo)
RR 0.98 [0.85, 1.13]1 study · 293 participantsLow
Downgraded: imprecision, indirectness
New infection within 1 week after initiation of treatment Assessed through clinical diagnosis
Glucocorticoid with cyclophosphamide plus usual care vs usual care (with or without placebo)
no estimate extracted0 studies · 0 participantsVery low
Downgraded: imprecision, indirectness